tyrosine has been researched along with Albuminuria in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Abramson, MH; Adegbite, BO; Azeloglu, EU; Berman, EM; Campbell, KN; Chan, L; Chauhan, K; Coca, SG; El Ghaity-Beckley, S; Gutgarts, V; Jaimes, EA; Kremyanskaya, M; Marcellino, B; Mascarenhas, JO; Meliambro, KA; Musteata, FM; Muwonge, AN; Salvatore, SP | 1 |
| Delcheva, GT; Maneva, AI; Stankova, TR; Vladeva, SV | 1 |
| Cai, L; Cui, W; Fu, Y; Miao, L; Miao, X; Su, G; Sun, W; Tan, Y; Wang, B; Wang, Y; Xin, Y | 1 |
| Chang, JH; Han, SH; Kang, HY; Kang, SW; Kim, S; Lee, SH; Nam, BY; Oh, HJ; Paeng, J; Park, JT; Yoo, TH | 1 |
| Hashimoto, T; Hirawa, N; Imai, N; Ishigami, T; Kihara, M; Kitamura, H; Kiuchi, Y; Nomura, K; Tamura, K; Toya, Y; Umemura, S; Yasuzaki, H; Yoshida, S | 1 |
| Cai, L; Guo, W; Ji, S; Li, C; Li, X; Tan, Y; Zhang, C | 1 |
| Ferrario, CM; Habibi, J; Hayden, MR; Johnson, MS; Nistala, R; Rehmer, N; Schneider, RI; Sowers, JR; Tilmon, R; Whaley-Connell, A | 1 |
| Maksimchyk, Y; Obrosova, IG; Shevalye, H; Watcho, P | 1 |
| Bosnyak, E; Koller, A; Komoly, S; Marko, L; Nagy, J; Pusch, G; Szapary, L; Toth, P; Wittmann, I | 1 |
| Adaikalakoteswari, A; Parving, HH; Rabbani, N; Rossing, K; Rossing, P; Tarnow, L; Thornalley, PJ | 1 |
| Bruno, RM; Daghini, E; Di Paco, I; Ghiadoni, L; Landini, L; Magagna, A; Salvati, A; Santini, E; Solini, A; Taddei, S; Versari, D | 1 |
| Fujishima, H; Fujita, H; Komatsu, K; Morii, T; Narita, T; Sakamoto, T; Takahashi, T; Yamada, Y | 1 |
| Burns, WC; Cooper, ME; Forbes, JM; Founds, HW; Jerums, G; Thallas, V; Thomas, MC | 1 |
| Fujita, T; Goto, A; Onozato, ML; Tojo, A; Wilcox, CS | 1 |
| Iwao, H; Kawano, H; Kim, S; Zhan, Y | 1 |
| Holmgren, G; Nordström, S; Thorburn, W | 1 |
| Berggård, I; Evrin, PE; Peterson, PA | 1 |
2 trial(s) available for tyrosine and Albuminuria
| Article | Year |
|---|---|
Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria.
Topics: Albuminuria; Amino Acids; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Bendroflumethiazide; Biomarkers; Biphenyl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Female; Glycation End Products, Advanced; Glycosylation; Humans; Hypertension; Irbesartan; Male; Oxidative Stress; Tetrazoles; Tyrosine | 2012 |
Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Benzimidazoles; Benzoates; Cross-Over Studies; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Japan; Losartan; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Superoxide Dismutase; Telmisartan; Tyrosine | 2011 |
15 other study(ies) available for tyrosine and Albuminuria
| Article | Year |
|---|---|
Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity.
Topics: Albuminuria; Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Proteinuria; Tyrosine | 2023 |
Serum Levels of Carbamylated LDL, Nitrotyrosine and Soluble Lectin-like Oxidized Low-density Lipoprotein Receptor-1 in Poorly Controlled Type 2 Diabetes Mellitus.
Topics: Adult; Albuminuria; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Scavenger Receptors, Class E; Tyrosine | 2019 |
Therapeutic effect of MG132 on the aortic oxidative damage and inflammatory response in OVE26 type 1 diabetic mice.
Topics: Albuminuria; Animals; Aorta; Blood Pressure; Diabetes Mellitus, Experimental; Hyperglycemia; Leupeptins; Mice; Mice, Transgenic; NF-E2-Related Factor 2; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation | 2013 |
Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions.
Topics: Albuminuria; Animals; Apoptosis; Apoptosis Regulatory Proteins; Diabetes Mellitus, Experimental; Glucose; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Kidney Glomerulus; Male; Oximes; Phosphorylation; Podocytes; Rats, Sprague-Dawley; Signal Transduction; Streptozocin; Tyrosine | 2014 |
Urinary oxidative stress markers closely reflect the efficacy of candesartan treatment for diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Deoxyguanosine; Diabetes Mellitus; Diabetic Nephropathies; Dinoprost; Disease Models, Animal; Hydralazine; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Tetrazoles; Treatment Outcome; Tyrosine | 2009 |
Attenuation of diabetes-induced renal dysfunction by multiple exposures to low-dose radiation is associated with the suppression of systemic and renal inflammation.
Topics: Albuminuria; Aldehydes; Animals; Blotting, Western; Chemokine CCL2; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Intercellular Adhesion Molecule-1; Interleukin-18; Male; Mice; Mice, Inbred C57BL; Nephritis; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA; Serpin E2; Serpins; Tumor Necrosis Factor-alpha; Tyrosine | 2009 |
Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
Topics: Albuminuria; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Pressure; Fumarates; Glomerular Filtration Rate; Hypertension; Irbesartan; Kidney; Membrane Glycoproteins; Membrane Proteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Podocytes; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles; Tyrosine | 2010 |
Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease.
Topics: Albuminuria; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Experimental; Enzyme-Linked Immunosorbent Assay; Hypertrophy; Immunohistochemistry; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Transforming Growth Factor beta1; Tyrosine | 2010 |
Microalbuminuria, indicated by total versus immunoreactive urinary albumins, in acute ischemic stroke patients.
Topics: Aged; Albuminuria; Biomarkers; Brain Ischemia; Chi-Square Distribution; Chromatography, High Pressure Liquid; Creatinine; Humans; Hungary; Immunoassay; Linear Models; Nephelometry and Turbidimetry; Predictive Value of Tests; Prevalence; Prognosis; Severity of Illness Index; Stroke; Tyrosine | 2011 |
Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes.
Topics: Adult; Albuminuria; Blood Glucose; Case-Control Studies; Comorbidity; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Nitroglycerin; Oxidative Stress; Regional Blood Flow; Tyrosine; Ultrasonography; Vasodilation; Vasodilator Agents | 2011 |
The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.
Topics: Albuminuria; Animal Population Groups; Animals; Blood Pressure; Collagen; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Glycation End Products, Advanced; Immediate-Early Proteins; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Kidney; Kinetics; Lysine; Models, Biological; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Solubility; Thiazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tyrosine | 2003 |
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Female; Hydrogen Peroxide; Isoquinolines; Kidney; Lipid Peroxidation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoproteins; Proteinuria; Quinapril; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Superoxides; Tetrahydroisoquinolines; Tetrazoles; Tyrosine | 2002 |
Enhancement of glomerular platelet-derived growth factor beta-receptor tyrosine phosphorylation in hypertensive rats and its inhibition by calcium channel blocker.
Topics: Albuminuria; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Genetic Predisposition to Disease; Hypertension; Kidney Glomerulus; Male; Phosphorylation; Proteinuria; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Platelet-Derived Growth Factor beta; Stroke; Tyrosine | 2002 |
Urinary metabolic studies in hereditary macular degeneration.
Topics: Albuminuria; Amino Acids; Carbohydrates; Cystinuria; Electrophoresis, Paper; Female; Glycosuria; Histidine; Humans; Keto Acids; Male; Pedigree; Phenylketonurias; Retinal Degeneration; Syndrome; Tyrosine | 1974 |
Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein.
Topics: Acidosis, Renal Tubular; Albuminuria; Amino Acid Metabolism, Inborn Errors; Cadmium Poisoning; Creatinine; Cystinosis; Diagnosis, Differential; Female; Glomerulonephritis; Hepatolenticular Degeneration; Humans; Immune Sera; Immunodiffusion; Kidney Glomerulus; Kidney Tubules; Laurence-Moon Syndrome; Male; Molecular Weight; Nephritis, Hereditary; Nephrotic Syndrome; Proteinuria; Serum Globulins; Tyrosine | 1969 |